INIS
adolescents
100%
children
100%
growth hormone
100%
height
90%
growth
45%
comparative evaluations
36%
data
27%
control
27%
quality of life
27%
humans
18%
cost
9%
range
9%
therapy
9%
inclusions
9%
gain
9%
libraries
9%
pharmaceuticals
9%
adults
9%
randomness
9%
secretion
9%
Medicine and Dentistry
Adolescence
100%
Recombinant Growth Hormone
100%
Idiopathic Short Stature
100%
Growth Hormone
100%
Randomized Controlled Trial
42%
Quality of Life
42%
Adverse Event
28%
Human Growth Hormone
28%
Placebo
28%
Self Concept
14%
Growth Hormone Release
14%
Health Care Cost
14%
Random Effects Model
14%
Treatment Effect
14%
Endocrine Therapy
14%
Nursing and Health Professions
Adolescent
100%
Growth Hormone
100%
Short Stature
100%
Recombinant Growth Hormone
100%
Quality of Life
37%
Placebo
25%
Adverse Event
25%
Human Growth Hormone
25%
Cochrane Library
12%
SciSearch
12%
Confidence Interval
12%
Body Height
12%
Pharmacology, Toxicology and Pharmaceutical Science
Growth Hormone
100%
Short Stature
100%
Recombinant Growth Hormone
100%
Randomized Controlled Trial
37%
Placebo
25%
Adverse Event
25%
Human Growth Hormone
25%
Random Effects Model
12%
Endocrine Therapy
12%
Agricultural and Biological Sciences
Bovine Somatotropin
100%
Adolescence
100%
Growth Hormone Treatment
100%
Quality of Life
27%
Adverse Effects
18%
Placebo
18%
Psychology
9%
Confidence Interval
9%